Corticosteroids Inhibit Il-12 Production In Human Monocytes And Enhance Their Capacity To Induce Il-4 Synthesis In Cd4+ Lymphocytes

We examined the effects of corticosteroids on IL-12 production by human monocytes and on cytokine synthesis in T cells. To distinguish the effects of corticosteroids on the APC used to activate the T cell from direct effects of corticosteroids on the T cell, experiments were performed by exposing the APC and not the T cell to corticosteroids. We found that corticosteroids significantly inhibited the production in monocytes of IL-12, a cytokine that is extremely potent in enhancing IFN-γ and inhibiting IL-4 synthesis in T cells. We demonstrated that reduced production of IL-12 in corticosteroid-treated monocytes resulted in a decreased capacity of the monocytes to induce IFN-γ and an increased ability to induce IL-4 in T cells. These results suggest that although corticosteroids may be beneficial for the treatment of asthma or allergic disease due to direct inhibitory effects of corticosteroids on cytokine synthesis in T cells, chronic corticosteroid therapy may indirectly exacerbate the long-term course of allergic disease. This deleterious effect of corticosteroids would result from a limitation in IL-12 production in tissue monocytes and macrophages, which would enhance production of Th2 cytokines (which augment allergic disease), and would reduce production of Th1 cytokines (which attenuate allergic disease) in T cells that subsequently infiltrate the tissues.1581255895595Goulding, N.J., Guyre, P.M., Glucocorticoids, lipocortins and the immune response (1993) Curr. Opin. Immunol., 5, p. 108Gillis, S., Crabtree, G.R., Smith, K.A., Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation (1979) J. Immunol., 123, p. 1624Arya, S.K., Wong-Staal, F., Gallo, R.C., Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA (1984) J. Immunol., 133, p. 273Schleimer, R.P., Bochner, B.S., The effects of glucocorticoids on human eosinophils (1994) J. Allergy Clin. Immunol., 94, p. 1202(1992) International Consensus Report on Diagnosis and Management of Asthma, , U.S. Public Health Service, Washington, DCRobinson, D.S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A.M., Corrigan, C., Kay, A.B., Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma (1992) N. Engl. J. Med., 326, p. 298Busse, W.W., Coffman, R.L., Gelfand, E.W., Kay, A.B., Rosenwasser, L.J., Mechanisms of persistent airway inflammation in asthma: A role for T cells and T-cell products (1995) Am. J. Respir. Crit. Care Med., 152, p. 388Umetsu, D.T., Bocian, R.C., DeKruyff, R.H., Restricted lymphokine synthesis in CD4+ helper T cells: New insights into the regulation of IgE synthesis and into the pathogenesis of allergic disease (1992) Pediatr. Asthma Allergy Immunol., 6, p. 1Romagnani, S., Lymphokine production by human T cells in disease states (1994) Annu. Rev. Immunol., 12, p. 227Bousquet, J., Chanez, P., Lacoste, J.Y., Barneon, G., Ghavanian, N., Enander, I., Venge, P., Godard, P., Eosinophilic inflammation in asthma (1990) N. Engl. J. Med., 323, p. 1033Gundel, R.H., Letts, L.G., Gleich, G.J., Human eosinophil major basic-protein induces airway constriction and airway hyperresponsiveness in primates (1991) J. Clin. Invest., 87, p. 1470Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., Baldwin Jr., A.S., Role of transcriptional activation of IκB alpha in mediation of immunosuppression by glucocorticoids (1995) Science, 270, p. 283Auphan, N., Didonato, J.A., Rosette, C., Helmberg, A., Karin, M., Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of I kappa B synthesis (1995) Science, 270, p. 286Barnes, P.J., Molecular mechanisms of steroid action in asthma (1996) J. Allergy Clin. Immunol., 97, p. 159Wu, C.Y., Fargeas, C., Nakajima, T., Delespesse, G., Glucocorticoids supress the production of interleukin 4 by human lymphocytes (1991) Eur. J. Immunol., 21, p. 2645Leung, D.Y., Martin, R.J., Szefler, S.J., Sher, E.R., Ying, S., Kay, A.B., Hamid, Q., Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma (1995) J. Exp. Med., 181, p. 33Ramirez, F., Fowell, D.J., Puklavec, M., Simmonds, S., Mason, D., Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro (1996) J. Immunol., 156, p. 2406Daynes, R.A., Araneo, B.A., Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4 (1989) Eur. J. Immunol., 19, p. 2319Zieg, G., Lack, G., Harbeck, R.J., Gelfand, E.W., Leung, D.Y., In vivo effects of glucocorticoids on IgE production (1994) J. Allergy Clin. Immunol., 94, p. 222Trinchieri, G., InterIeukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity (1995) Annu. Rev. Immunol., 13, p. 251Marshall, J.D., Secrist, H., DeKruyff, R.H., Wolf, S.F., Umetsu, D.T., IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes (1995) J. Immunol., 155, p. 111Secrist, H., DeKruyff, R.H., Umetsu, D.T., Interleukin 4 production by CD4+ cells from allergic individuals is modulated by allergen concentration and antigen-presenting cell type (1995) J. Exp. Med., 181, p. 1081Marshall, J., Wen, Y., Abrams, J.S., Umetsu, D.T., In vitro synthesis of IL-4 by human CD4+ T cells requires repeated antigenic stimulation (1993) Cell. Immunol., 152, p. 18Li, Y., Ito, N., Suzuki, T., Stechschulte, D.J., Dileepan, K.N., Dexamethasone inhibits nitric oxide-mediated cytotoxicity via effects on both macrophages and target cells (1995) Immunopharmacology, 30, p. 177Constant, S., Pfeiffer, C., Woodard, A., Pasqualini, T., Bottomly, K., Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells (1995) J. Exp. Med., 182, p. 1591Viola, A., Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds (1996) Science, 273, p. 104Snijdewint, F.G., Kapsenberg, M.L., Wauben-Penris, P.J., Bos, J.D., Corticosteroids class-dependently inhibit in vitro Th1- And Th2-type cytokine production (1995) Immunopharmacology, 29, p. 93Masuyama, K., Jacobson, M.R., Rak, S., Meng, Q., Sudderick, R.M., Kay, A., Lowhagen, O., Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for inlerleukin-4 in the nasal mucosa in allergen-induced rhinitis (1994) Immunology, 82, p. 192Culpepper, J.A., Lee, F., Regulation of IL-3 expression by glucocorticoids in cloned murine T lymphocytes (1985) J. Immunol., 135, p. 3191Beutler, B., Krochin, N., Milsark, I.W., Luedke, C., Cerami, A., Control of cachectin synthesis: Mechanisms of endotoxin resistance (1986) Science, 232, p. 977Truss, M., Beato, M., Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors (1993) Endocrinol. Rev., 14, p. 459Yang-Yen, H.F., Chambard, J.C., Sun, Y.S., Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction (1990) Cell, 62, p. 1205Adcock, I.M., Brown, C.R., Gelder, C.M., Shirasaki, H., Peters, M.J., Barnes, P.J., The effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells (1995) Am. J. Physiol., 37, pp. C331Ray, A., Prefontaine, K.E., Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor (1994) Proc. Natl. Acad. Sci. USA, 91, p. 752Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., Baldwin Jr., A.S., Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids (1995) Science, 270, p. 283Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A., Karin, M., Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis (1995) Science, 270, p. 286Zembowicz, A., Vane, J.R., Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line (1992) Proc. Natl. Acad. Sci. USA, 89, p. 2051Breuninger, L.M., Dempsey, W.L., Uhl, J., Murasko, D.M., Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes (1993) Clin. Immunol. Immunopathol., 69, p. 205Heidenreich, S., Kubis, T., Schmidt, M., Fegeler, W., Glucocorticoid-induced alterations of monocyte defense mechanisms against Candida albicans (1994) Cell. Immunol., 157, p. 320Murphy, T.L., Cleveland, M.G., Kulesza, P., Magram, J., Murphy, K.M., Regulation of interleukin 12 p40 expression through an NF-κB half-site (1995) Mol. Cell. Biol., 15, p. 5258Manetti, R., Gerosa, F., Giudizi, M.G., Biagiotti, R., Parronchi, P., Piccinni, M., Sampognaro, S., Trinchieri, G., Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones (1994) J. Exp. Med., 179, p. 1273DeKruyff, R.H., Fang, Y., Wolf, S.F., Umetsu, D.T., IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ T cells through an effect on antigen-presenting cells (1995) J. Immunol., 154, p. 2578Murphy, E., Shibuya, K., Hosken, N., Openshaw, P., Maino, V., Davis, K., Murphy, K., O'Garra, A., Reversibility of T helper 1 and 2 populations is lost after long-term stimulation (1996) J. Exp. Med., 183, p. 901Jeannin, P., Delneste, Y., Seveso, M., Life, P., Bonnefoy, J.Y., IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells (1996) J. Immunol., 156, p. 3159Windhagen, A., Anderson, D.E., Carrizosa, A., Williams, R.E., Hafler, D.A., IL-12 induces human T cells secreting IL-10 with IFN-γ (1996) J. Immunol., 157, p. 1127Magram, J., Connaughton, S.E., Warrier, R.R., Carvajal, D.M., Wu, C.Y., Ferrante, J., Stewart, C., Gately, M.K., IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses (1996) Immunity, 4, p. 471Snyder, D.S., Unanue, E.R., Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production (1982) J. Immunol., 129, p. 1803Moser, M., De Smedt, T., Somasse, T., Tielemans, F., Chentoun, A.A., Muraille, E., Van Mechelen, M., Leo, O., Glucocorticoids down-regulate dendritic cell function in vitro and in vivo (1995) Eur. J. Immunol., 25, p. 281

Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma.

Immunotherapy for cancer aims to generate cytotoxic cells that are capable of eradicating tumour cells. It has been well demonstrated that helper, non-cytotoxic CD4(+) T cells are important for the induction and maintenance of anti-tumour immunity exerted by cytotoxic CD8(+) T cells. In contrast, the existence of direct anti-tumour, effector cytotoxic CD4(+) T cells remains elusive, mainly due to the paucity of reliable experimental data, especially in human B-cell non-Hodgkin lymphomas. This study developed an appropriate, autologous follicular B-cell non-Hodgkin follicular lymphoma model, including the in vitro establishment of a malignant, human leucocyte antigen class I (HLA-I) deficient B-cell line, and the generation of three autologous anti-tumour cytotoxic CD4(+) T-cell clones originating from the peripheral blood of the same patient. These three clones were considered as tumour specific, because they were capable of killing the malignant, HLA-I-deficient B-cell line through a classical HLA-II restricted perforin-mediated pathway, but did not lyse the Epstein-Barr virus-infected autologous normal B lymphocytes. All three CD4(+)clones were T-cell receptor Vbeta17-Dbeta1-Jbeta1.2 and exhibited an identical complementarity-determining region 3, suggesting the immunodominance of a single peptide antigen presented by tumour cells. Such lymphoma models would provide a useful tool for in vivo expansion and the adoptive transfer of selected CD4(+) cytotoxic cells in immunotherapeutic strategies

Sulfasalazine prevents T-helper 1 immune response by suppressing interleukin-12 production in macrophages

Interleukin-12 (IL-12) plays a pivotal role in the development of T-helper 1 (Th1) immune response, which may be involved in the pathogenesis of chronic inflammatory autoimmune disorders. In this study we investigated the effects of sulfasalazine, a drug for treating inflammatory bowel disease and rheumatoid arthritis, on the production of IL-12 from mouse macrophages stimulated with lipopolysaccharide (LPS). Sulfasalazine potently inhibited the production of IL-12 in a dose-dependent manner, in part through the down-regulation of nuclear factor κB (NFκB) activation in IL-12 p40 gene. Activation of macrophages by LPS resulted in markedly enhanced binding activities to the κB site, which significantly decreased upon addition of sulfasalazine as demonstrated by an electrophoretic gel shift assay. Importantly, macrophages pretreated with sulfasalazine either in vitro or in vivo reduced their ability to induce interferon-γ (IFN-γ) and increased the ability to induce IL-4 in antigen-primed CD4+ T cells. From these results, sulfasalazine may induce the Th2 cytokine profile in CD4+ T cells by suppressing IL-12 production in macrophages, and sulfasalazine-induced inhibition of IL-12 production in macrophages may explain some of the known biological effects of sulfasalazine